viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
uurimisrühmad - R&D Division, Biotechnology Research Institute, Celltrion
R&D Division, Biotechnology Research Institute, Celltrion
Incheon
Viited
(2)
1
Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17.
Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A. (YeonKyeong.Shin@celltrion.com)
Adv Ther -
2021
- ; 38 : 5609–5622
2
In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion.
Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y. (SuJung.Kim@celltrion.com)
Bio Drugs -
2018
- 32;619-625
molekulid uuritud
(2)
Adalimumab
Trastuzumab
Mentions Légales
